35,000 more European patients to get access to clinical trials if new EU targets are met
Date: 17 March 2026
A new report from the European Federation of Pharmaceutical Industries and Associations (EFPIA) highlights the significant health, economic and productivity returns that would result from increasing clinical trial activity across Europe